“Hepatoprotective Effect Of Epigallocatechin-Gallate (Egcg) And Sorafenib Against Den Induced Hepato Cellular Carcinoma In Experimental Animals”, Journal of Pharmaceutical Negative Results, pp. 921–929, Nov. 2022, doi: 10.47750/pnr.2022.13.S09.110.